Characterization of CYP2B6 and CYP2A6 Pharmacogenetic Variation in Sub‐Saharan African Populations

Author:

Twesigomwe David12ORCID,Drögemöller Britt I.3ORCID,Wright Galen E. B.45ORCID,Adebamowo Clement67ORCID,Agongo Godfred89ORCID,Boua Palwendé R.110ORCID,Matshaba Mogomotsi1112ORCID,Paximadis Maria1314ORCID,Ramsay Michèle12ORCID,Simo Gustave15ORCID,Simuunza Martin C.16ORCID,Tiemessen Caroline T.13ORCID,Lombard Zané2ORCID,Hazelhurst Scott117ORCID

Affiliation:

1. Sydney Brenner Institute for Molecular Bioscience, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

2. Division of Human Genetics, National Health Laboratory Service, and School of Pathology, Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

3. Department of Biochemistry and Medical Genetics, Rady Faculty of Health Sciences University of Manitoba Winnipeg Manitoba Canada

4. Neuroscience Research Program Kleysen Institute for Advanced Medicine, Winnipeg Health Sciences Centre and Max Rady College of Medicine, University of Manitoba Winnipeg Manitoba Canada

5. Department of Pharmacology and Therapeutics, Rady Faculty of Health Sciences University of Manitoba Winnipeg Manitoba Canada

6. Institute for Human Virology Abuja Nigeria

7. Division of Cancer Epidemiology, Department of Epidemiology and Public Health, and the Marlene and Stewart Greenebaum Comprehensive Cancer Centre University of Maryland School of Medicine Baltimore Maryland USA

8. Navrongo Health Research Centre, Ghana Health Service Navrongo Ghana

9. Department of Biochemistry and Forensic Sciences, School of Chemical and Biochemical Sciences C.K. Tedam University of Technology and Applied Sciences Navrongo Ghana

10. Clinical Research Unit of Nanoro Institut de Recherche en Sciences de la Santé Nanoro Burkina Faso

11. Botswana‐Baylor Children's Clinical Centre of Excellence Gaborone Botswana

12. Retrovirology, Department of Pediatrics Baylor College of Medicine Houston Texas USA

13. Centre for HIV and STIs, National Institute for Communicable Diseases, National Health Laboratory Services and Faculty of Health Sciences University of the Witwatersrand Johannesburg South Africa

14. School of Molecular and Cell Biology University of the Witwatersrand Johannesburg South Africa

15. Molecular Parasitology and Entomology Unit, Department of Biochemistry, Faculty of Science University of Dschang Dschang Cameroon

16. Department of Disease Control, School of Veterinary Medicine University of Zambia Lusaka Zambia

17. School of Electrical and Information Engineering University of the Witwatersrand Johannesburg South Africa

Abstract

Genetic variation in CYP2B6 and CYP2A6 is known to impact interindividual response to antiretrovirals, nicotine, and bupropion, among other drugs. However, the full catalogue of clinically relevant pharmacogenetic variants in these genes is yet to be established, especially across African populations. This study therefore aimed to characterize the star allele (haplotype) distribution in CYP2B6 and CYP2A6 across diverse and understudied sub‐Saharan African (SSA) populations. We called star alleles from 961 high‐depth full genomes using StellarPGx, Aldy, and PyPGx. In addition, we performed CYP2B6 and CYP2A6 star allele frequency comparisons between SSA and other global biogeographical groups represented in the new 1000 Genomes Project high‐coverage dataset (n = 2,000). This study presents frequency information for star alleles in CYP2B6 (e.g., *6 and *18; frequency of 21–47% and 2–19%, respectively) and CYP2A6 (e.g., *4, *9, and *17; frequency of 0–6%, 3–10%, and 6–20%, respectively), and predicted phenotypes (for CYP2B6), across various African populations. In addition, 50 potentially novel African‐ancestry star alleles were computationally predicted by StellarPGx in CYP2B6 and CYP2A6 combined. For each of these genes, over 4% of the study participants had predicted novel star alleles. Three novel star alleles in CYP2A6 (*54, *55, and *56) and CYP2B6 apiece, and several suballeles were further validated via targeted Single‐Molecule Real‐Time resequencing. Our findings are important for informing the design of comprehensive pharmacogenetic testing platforms, and are highly relevant for personalized medicine strategies, especially relating to antiretroviral medication and smoking cessation treatment in Africa and the African diaspora. More broadly, this study highlights the importance of sampling diverse African ethnolinguistic groups for accurate characterization of the pharmacogene variation landscape across the continent.

Funder

National Human Genome Research Institute

Wellcome Trust

Bill and Melinda Gates Foundation

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3